Evidence map›Paper›PMID 25504918›Full record

Trial reportHuman brain mapping2015

Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication.

Nathan L Hutcheson, Karthik R Sreenivasan, Gopikrishna Deshpande, Meredith A Reid, Jennifer Hadley, David M White, Lawrence Ver Hoef, Adrienne C Lahti

Abstract readClinical Trial
In one paragraph

Trial report in Human brain mapping, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Functioning Problems in Persons with Schizophrenia in the Russian Context.International journal of environmental research and public health · 2021
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Nathan L HutchesonDepartment of Psychiatry and Behavioral Neurobiology, The University of Alabama at Birmingham, Birmingham, Alabama.
Karthik R Sreenivasan
Gopikrishna Deshpande
Meredith A Reid
Jennifer Hadley
David M White
Lawrence Ver Hoef
Adrienne C Lahti
University of Alabama at Birmingham · USAuburn University · US

Funding

Glutamate, brain connectivity and duration of untreated psychosisR01MH102951 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LAHTI, ADRIENNE C · 2014 to 2018
$2.9M
Treatment response in schizophrenia: bridging imaging and postmortem studiesR01MH081014 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LAHTI, ADRIENNE C · 2009 to 2013
$1.8M
Novel MRI Techniques to Image Hippocampal Internal ArchitectureK23EB008452 · NIBIB · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI VER HOEF, LAWRENCE · 2009 to 2013
$878k
NIBIB NIH HHS K23 EB008452NIBIB NIH HHS K23EB008452NIMH NIH HHS R01 MH081014NIMH NIH HHS R01 MH102951
6 · The paper itself

Abstract

backgroundImpairment in episodic memory is one of the most robust findings in schizophrenia. Disruptions of fronto-temporal functional connectivity that could explain some aspects of these deficits have been reported. Recent work has identified abnormal hippocampal function in unmedicated patients with schizophrenia (SZ), such as increased metabolism and glutamate content that are not always seen in medicated SZ. For these reasons, we hypothesized that altered fronto-temporal connectivity might originate from the hippocampus and might be partially restored by antipsychotic medication.

methodsGranger causality methods were used to evaluate the effective connectivity between frontal and temporal regions in 21 unmedicated SZ and 20 matched healthy controls (HC) during performance of an episodic memory retrieval task. In 16 SZ, effective connectivity between these regions was evaluated before and after 1-week of antipsychotic treatment.

resultsIn HC, significant effective connectivity originating from the right hippocampus to frontal regions was identified. Compared to HC, unmedicated SZ showed significant altered fronto-temporal effective connectivity, including reduced right hippocampal to right medial frontal connectivity. After 1-week of antipsychotic treatment, connectivity more closely resembled the patterns observed in HC, including increased effective connectivity from the right hippocampus to frontal regions.

conclusionsThese results support the notion that memory disruption in schizophrenia might originate from hippocampal dysfunction and that medication restores some aspects of fronto-temporal dysconnectivity. Patterns of fronto-temporal connectivity could provide valuable biomarkers to identify new treatments for the symptoms of schizophrenia, including memory deficits.

Indexed as

Memory, EpisodicAdultAntipsychotic AgentsBrainBrain MappingCausalityFemaleHumansMagnetic Resonance ImagingMaleNeural PathwaysNeuropsychological TestsPsychiatric Status Rating ScalesPsychotic DisordersRisperidoneSchizophreniaAntipsychotic AgentsRisperidoneantipsychotic medicationeffective connectivityepisodic memoryfunctional connectivityhippocampusmemory encodingmemory retrievalprefrontal cortexschizophreniaunmedicated

Identifiers

PMID25504918
PMCPMC6430201
OpenAlexW1495459926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.